title: Inter-laboratory evaluation of the COBAS INTEGRA 400 analytical system.
abstract: COBAS INTEGRA 400 is a random-access analytical system consolidating assays for clinical chemistry analytes, electrolytes, serum proteins, drugs of abuse and therapeutic drugs. Analytical performance and practicability of the instrument were evaluated in seven laboratories over a 2-year period in parallel with system development. Good within-run and total imprecision for all assays was observed with a few exceptions for specimen pools with low concentration or activity. The coefficients of variation for total imprecision were well below 3.0% for clinical chemistry analytes and electrolytes, and below 5.0% for serum proteins and therapeutic drugs. Method comparisons demonstrated a good agreement with the various systems used for comparison, with slopes varying typically from 0.94 to 1.05, and Spearman correlation coefficient generally > 0.975. Accuracy was verified by recovery of controls and certified reference materials within 90 to 110% of target values. Assay ranges were linear within +/- 5%. No carry-over on reagent or sample pipetting systems was observed. Manufacturer-specified interference limits and onboard stabilities of reagents were confirmed. A time study for calculating direct personnel times and total processing time was carried out in three laboratories under different conditions including consolidated, STAT and dedicated use. On a scenario-independent basis, the total working time was shorter on the COBAS INTEGRA 400 than on routine systems in all three laboratories. Personnel time, in particular, was significantly reduced when compared to routine instruments. In general, system practicability was judged very positively in all laboratories. Owing to its versatility, the instrument is best placed as a consolidated workstation in small- to medium-sized laboratories or as an instrument for special determinations such as serum proteins, drugs, urinalysis or emergency analyses in large laboratories.
authors.affiliation: Klinisch-Chemisches Labor, Kantonsspital Bruderholz, Switzerland. juergen.muser@ksbh.ch
authors.forename: J
authors.initials: J
authors.lastname: Muser
authors.forename: J
authors.initials: J
authors.lastname: Bienvenu
authors.forename: N
authors.initials: N
authors.lastname: Blanckaert
authors.forename: I
authors.initials: I
authors.lastname: Brandslund
authors.forename: J
authors.initials: J
authors.lastname: Delattre
authors.forename: G
authors.initials: G
authors.lastname: Soffiati
authors.forename: R
authors.initials: R
authors.lastname: Swaminathan
authors.forename: S
authors.initials: S
authors.lastname: Maggini
authors.forename: H
authors.initials: H
authors.lastname: Mastall
mesh_terms: D001798:Blood Proteins / Q000032:analysis; D002624:Chemistry, Clinical / Q000295:instrumentation* / Q000592:standards / Q000706:statistics & numerical data; D004573:Electrolytes / Q000032:analysis; D004798:Enzymes / Q000032:analysis; D005060:Europe; D006801:Humans; D013287:Illicit Drugs / Q000032:analysis; D007202:Indicators and Reagents; D007753:Laboratories; D004364:Pharmaceutical Preparations / Q000032:analysis; D015203:Reproducibility of Results; D012984:Software
chemical_list: D001798:Blood Proteins; D004573:Electrolytes; D004798:Enzymes; D013287:Illicit Drugs; D007202:Indicators and Reagents; D004364:Pharmaceutical Preparations